Support to Public Private Partnerships - Extending HIV Workplace Programmes to BRALIMA’s supply chain
The implementation of HIV workplace programmes in BRALIMA’s supply chain in Kinshasa will reduce the detrimental effects of HIV on the workforce and on society. Objectives are the reduction of HIV by improved access to preventive services; knowledge and HIV treatment for certain groups; create best practice and example on the role of business in HIV prevention; help to reinvigorate the business coalition in DRC. This intervention creates much attention within the emerging private sector, especially within large companies in DRC. As BRALIMA has breweries in 6 different provinces, the intervention is visible and lessons learnt are communicated directly in the field and via mass media.
The specific objective is to motivate supply chain companies in Kinshasa to set up their own HIV workplace programme. The methods used generally follow the guidelines set up by the WEF.
Elements of the programme are inter alia:
- A written workplace HIV policy setting out the companies policy on HIV and including nondiscrimination or activities to reduce stigma;
- General health education on HIV;
- Peer educators and peer educator training;
- Access to condoms;
- Access to) VCT;
- Access to HIV treatment, PMTCT, STI treatment etc.;
- The programme can also include family activities, support for HIV patients, AIDS day activities.
The programme elements are implemented by setting up an HIV committee per supply chain company being responsible for their implementation. Training is organized through use of external trainers followed by peer educator sessions.
- Provision of Project Manager (full time, 24 month) and Project Assistant;
- Implementation of activities (KAP studies, Trainings, VCT sessions, workshops);
- Introduction of a HIV workplace policy in supply chain companies;
- Trainings on HIV and AIDS: awareness raising, health education;
- Peer educator training;
- Provision of free access to condoms;
- Organisation of VCT access and HIV treatment within existing structures;